Recombinant Human DLL1 protein (ab108576)
Key features and details
- Expression system: HEK 293 cells
- Purity: > 90% SDS-PAGE
- Endotoxin level:
- Tags: DDDDK tag C-Terminus
- Suitable for: Functional Studies, SDS-PAGE
Preparation and Storage
-
Stability and Storage
Shipped at 4°C. Upon delivery aliquot and store at -20°C. Avoid freeze / thaw cycles.
Constituent: PBS
Images
-
Functional Studies - Recombinant Human DLL1 protein (ab108576)Adipogenesis inhibition of MSCs.
MSCs (Mesenchymal stem cells) were maintained in DMEM, supplemented with 10% fetal bovine serum, penicilin-streptomycin and glutamine. For differentiation of MSCs, MSCs were cultured in adipogenic medium which was growth medium supplemented with 1μM Dexamethasone, 0.5mM IBMX, 10μg/m lnsulin, 100μM Indomethacin (day 1). Medium was changed every 3 days. Staining with Oil Red O was typically performed on day 30. For negative controls, TNF-alpha (20ng/ml) was added. To immobilize Notch ligands on the plastic surface of the culture plates, plates were first incubated with a solution of anti-FLAG® antibody (10μg/ml) in PBS for 30 mins at 37°C. Coated plates were blocked with growth medium for at least 30mins, incubated with solution of ab108576 (5μg/ml) or mCD137L-FLAG® (5μg/ml) in growth medium for 2 hours at 37°C. Plates were then used to differentiate MSCs.
